Vol 2007, No 81 (2007)

Table of Contents

Cartoons

Nearly jpg
Business Review Editor

Deal Trackers

Advexin (adenoviral p53) Abstract pdf
Business Review Editor

Research & Development

VASTox Signs Drug Discovery Deals Worth a Combined US$1.3 M Abstract pdf
Business Review Editor

Features

Flexibility and Fortune: AstraZeneca’s Strategic Shift Abstract pdf
Business Review Editor
H5N1: Preparing for the Worst Abstract pdf
Business Review Editor
The Pharmaceutical Deals of 2006: Lessons for 2007 Abstract pdf
Business Review Editor
Viral Gene Delivery #8211; Gene Therapy and Beyond Abstract pdf
Business Review Editor

Licensing

GSK and XenoPort to Collaborate on Late-Stage Compound for RLS and Neuropathic Pain Abstract pdf
Business Review Editor
Elbion in Deals for Neurological Products Abstract pdf
Business Review Editor

General

Synergy or Vanity: the Appetite for Pharma Mega-Mergers Abstract
Business Review Editor
Amsterdam Molecular Therapeutics (AMT B.V.) Abstract
Business Review Editor

Mergers & Acquisitions

Cardinal Divests Segment to Blackstone Abstract pdf
Business Review Editor
Hikma Set to Enter Oncology Market with Acquisition of ribosepharm Abstract pdf
Business Review Editor

Business Commentaries

What's a good pipeline? Abstract html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.